Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

PTC Therapeutics, Inc. (PTCT)

-NasdaqGS
24.51 Up 0.09(0.37%) Jul 11, 4:00PM EDT
Prev Close:24.42
Open:24.34
Bid:24.17 x 300
Ask:26.50 x 200
1y Target Est:39.75
Beta:-2.138
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:24.16 - 25.93
52wk Range:13.15 - 34.65
Volume:110,367
Avg Vol (3m):475,331
Market Cap:718.76M
P/E (ttm):N/A
EPS (ttm):-2.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PTCT

Comparison

Symbol% ChgMkt Cap
PTCTUp 0.37%718.76M
SRPTDown 2.48%894.10M
VRTXUp 1.28%23.40B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.01
Quarterly EPS Est (Jun-14) :-0.74
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback